FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2620796881> ?p ?o ?g. }

• W2620796881 endingPage "72" @default.
• W2620796881 startingPage "56" @default.
• W2620796881 abstract "Renin-angiotensin system (RAS) plays a key role in the development and progression of chronic kidney disease (CKD). Recent studies have demonstrated activation of Wnt/β-catenin pathway by RAS in CKD. However, the underlying mechanisms of RAS and Wnt/β-catenin signaling interaction and their contribution to the pathogenesis of CKD have not been fully elucidated. Present study is designed to investigate the role of RAS/Wnt/β-catenin axis activation in tubulo-interstitial fibrosis and glomerulosclerosis by the cultured HK-2 and podocytes. HK-2 cells and podocytes are treated by angiotensin II (Ang II). Ang II up-regulates expression of various Wnt mRNA and active β-catenin protein in HK-2 cells and podocytes in the time- and dose-dependent manners. In addition, Ang II induces injury, oxidative stress and inflammation and impaired Nrf2 activation in HK-2 cells and podocytes. This was accompanied by up-regulations of RAS components as well as Wnt1, activated β-catenin and its target proteins. RAS/Wnt/β-catenin axis activation results in epithelial-to-mesenchymal transition in HK-2 cells and injuries podocytes. The effect of Ang II is inhibited by losartan and ICG-001, a Wnt/β-catenin inhibitor. We further found that treatment with natural products, ergone, alisol B 23-acetate and pachymic acid B inhibit extracellular matrix accumulation in HK-2 cells and attenuated podocyte injury, in part, by inhibiting Ang II induced RAS/Wnt/β-catenin axis activation. In summary, activation of RAS/Wnt/β-catenin axis results in podocytes and tubular epithelial cell, injury and up-regulations of oxidative, inflammatory and fibrotic pathways. These adverse effects are ameliorated by ergone, alisol B 23-acetate and pachymic acid B. Therefore, these natural products could be considered as novel Wnt/β-catenin signaling inhibitors and anti-fibrotic agents." @default.
• W2620796881 created "2017-06-09" @default.
• W2620796881 creator A5006012404 @default.
• W2620796881 creator A5038798689 @default.
• W2620796881 creator A5043016170 @default.
• W2620796881 creator A5056238061 @default.
• W2620796881 creator A5071389166 @default.
• W2620796881 creator A5078143614 @default.
• W2620796881 creator A5087559896 @default.
• W2620796881 creator A5088303852 @default.
• W2620796881 date "2017-08-01" @default.
• W2620796881 modified "2023-10-18" @default.
• W2620796881 title "Role of RAS/Wnt/β-catenin axis activation in the pathogenesis of podocyte injury and tubulo-interstitial nephropathy" @default.
• W2620796881 cites W1665231149 @default.
• W2620796881 cites W1822496266 @default.
• W2620796881 cites W1897148373 @default.
• W2620796881 cites W1963627331 @default.
• W2620796881 cites W1982670131 @default.
• W2620796881 cites W1991667666 @default.
• W2620796881 cites W2002518738 @default.
• W2620796881 cites W2006343568 @default.
• W2620796881 cites W2006419043 @default.
• W2620796881 cites W2015200944 @default.
• W2620796881 cites W2016855913 @default.
• W2620796881 cites W2035019335 @default.
• W2620796881 cites W2041838284 @default.
• W2620796881 cites W2045332239 @default.
• W2620796881 cites W2058539932 @default.
• W2620796881 cites W2065710264 @default.
• W2620796881 cites W2066592814 @default.
• W2620796881 cites W2067218262 @default.
• W2620796881 cites W2071497196 @default.
• W2620796881 cites W2077049255 @default.
• W2620796881 cites W2083738957 @default.
• W2620796881 cites W2084162854 @default.
• W2620796881 cites W2092775138 @default.
• W2620796881 cites W2093675879 @default.
• W2620796881 cites W2094199236 @default.
• W2620796881 cites W2103170336 @default.
• W2620796881 cites W2105611069 @default.
• W2620796881 cites W2105663114 @default.
• W2620796881 cites W2114614037 @default.
• W2620796881 cites W2124602789 @default.
• W2620796881 cites W2126508026 @default.
• W2620796881 cites W2136143828 @default.
• W2620796881 cites W2148477482 @default.
• W2620796881 cites W2148479501 @default.
• W2620796881 cites W2153483645 @default.
• W2620796881 cites W2160109224 @default.
• W2620796881 cites W2163587286 @default.
• W2620796881 cites W2165936048 @default.
• W2620796881 cites W2169453638 @default.
• W2620796881 cites W2179115815 @default.
• W2620796881 cites W2294558427 @default.
• W2620796881 cites W2299953595 @default.
• W2620796881 cites W2339851852 @default.
• W2620796881 cites W2344010846 @default.
• W2620796881 cites W2347076418 @default.
• W2620796881 cites W2401600644 @default.
• W2620796881 cites W2468270002 @default.
• W2620796881 cites W2468914978 @default.
• W2620796881 cites W2519730045 @default.
• W2620796881 cites W2524261334 @default.
• W2620796881 cites W2540592856 @default.
• W2620796881 cites W2596441513 @default.
• W2620796881 cites W2604064468 @default.
• W2620796881 cites W2604524306 @default.
• W2620796881 doi "https://doi.org/10.1016/j.cbi.2017.05.025" @default.
• W2620796881 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28578904" @default.
• W2620796881 hasPublicationYear "2017" @default.
• W2620796881 type Work @default.
• W2620796881 sameAs 2620796881 @default.
• W2620796881 citedByCount "80" @default.
• W2620796881 countsByYear W26207968812017 @default.
• W2620796881 countsByYear W26207968812018 @default.
• W2620796881 countsByYear W26207968812019 @default.
• W2620796881 countsByYear W26207968812020 @default.
• W2620796881 countsByYear W26207968812021 @default.
• W2620796881 countsByYear W26207968812022 @default.
• W2620796881 countsByYear W26207968812023 @default.
• W2620796881 crossrefType "journal-article" @default.
• W2620796881 hasAuthorship W2620796881A5006012404 @default.
• W2620796881 hasAuthorship W2620796881A5038798689 @default.
• W2620796881 hasAuthorship W2620796881A5043016170 @default.
• W2620796881 hasAuthorship W2620796881A5056238061 @default.
• W2620796881 hasAuthorship W2620796881A5071389166 @default.
• W2620796881 hasAuthorship W2620796881A5078143614 @default.
• W2620796881 hasAuthorship W2620796881A5087559896 @default.
• W2620796881 hasAuthorship W2620796881A5088303852 @default.
• W2620796881 hasBestOaLocation W26207968812 @default.
• W2620796881 hasConcept C126322002 @default.
• W2620796881 hasConcept C134018914 @default.
• W2620796881 hasConcept C137620995 @default.
• W2620796881 hasConcept C170493617 @default.
• W2620796881 hasConcept C185592680 @default.
• W2620796881 hasConcept C2777146197 @default.
• W2620796881 hasConcept C2777390665 @default.
• W2620796881 hasConcept C2779324961 @default.

• next